Bingjun Zhang

1.5k total citations
60 papers, 1.0k citations indexed

About

Bingjun Zhang is a scholar working on Neurology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Bingjun Zhang has authored 60 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Neurology, 15 papers in Pathology and Forensic Medicine and 13 papers in Epidemiology. Recurrent topics in Bingjun Zhang's work include Peripheral Neuropathies and Disorders (12 papers), Multiple Sclerosis Research Studies (11 papers) and Neuroinflammation and Neurodegeneration Mechanisms (10 papers). Bingjun Zhang is often cited by papers focused on Peripheral Neuropathies and Disorders (12 papers), Multiple Sclerosis Research Studies (11 papers) and Neuroinflammation and Neurodegeneration Mechanisms (10 papers). Bingjun Zhang collaborates with scholars based in China, Canada and United States. Bingjun Zhang's co-authors include Zhengqi Lu, Yinyao Lin, Wei Cai, Wei Qiu, Yuge Wang, Xueqiang Hu, Yilong Shan, Mengyan Hu, Siyuan Liao and Xuejiao Men and has published in prestigious journals such as The Lancet, PLoS ONE and Neurology.

In The Last Decade

Bingjun Zhang

54 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bingjun Zhang China 19 263 258 203 202 196 60 1.0k
Brandon A. Miller United States 19 390 1.5× 203 0.8× 236 1.2× 228 1.1× 102 0.5× 64 1.2k
Mark A. Petersen United States 9 249 0.9× 583 2.3× 233 1.1× 180 0.9× 172 0.9× 12 1.3k
Ann Potter Australia 15 273 1.0× 374 1.4× 314 1.5× 118 0.6× 138 0.7× 24 1.2k
Orest Tsymbalyuk United States 18 384 1.5× 179 0.7× 337 1.7× 335 1.7× 196 1.0× 25 1.2k
Shu Han China 20 169 0.6× 139 0.5× 461 2.3× 260 1.3× 111 0.6× 58 1.2k
Xiaofeng Yang China 19 458 1.7× 174 0.7× 576 2.8× 84 0.4× 275 1.4× 65 1.4k
Supinder S. Bedi United States 22 430 1.6× 326 1.3× 416 2.0× 129 0.6× 151 0.8× 39 1.3k
Anna V. Leonard Australia 13 258 1.0× 121 0.5× 227 1.1× 136 0.7× 117 0.6× 29 747
Bushra Wali United States 14 252 1.0× 284 1.1× 284 1.4× 121 0.6× 173 0.9× 26 918
Elisabeth Andreadou Greece 16 503 1.9× 206 0.8× 166 0.8× 258 1.3× 99 0.5× 60 1.1k

Countries citing papers authored by Bingjun Zhang

Since Specialization
Citations

This map shows the geographic impact of Bingjun Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingjun Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingjun Zhang more than expected).

Fields of papers citing papers by Bingjun Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingjun Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingjun Zhang. The network helps show where Bingjun Zhang may publish in the future.

Co-authorship network of co-authors of Bingjun Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Bingjun Zhang. A scholar is included among the top collaborators of Bingjun Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingjun Zhang. Bingjun Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Han, Haotian Wu, Ping Liu, et al.. (2025). Safety and Efficacy of a Neonatal Fc Receptor Antagonist in Patients With Anti‐NMDAR Encephalitis. CNS Neuroscience & Therapeutics. 31(8). e70534–e70534. 2 indexed citations
2.
3.
Zhang, Bingjun, et al.. (2024). NSD2-mediated H3K36me2 exacerbates osteoporosis via activation of hoxa2 in bone marrow mesenchymal stem cells. Cellular Signalling. 121. 111294–111294. 2 indexed citations
4.
Zhang, Bingjun, et al.. (2023). Composite Classical Hodgkin Lymphoma and Mantle Cell Lymphoma: A Case Report. Cureus. 15(9). e45727–e45727.
5.
Li, Rui, Qiao Huang, Zifeng Liu, et al.. (2022). Immunosuppressant and neuromyelitis optica spectrum disorder: optimal treatment duration and risk of discontinuation. European Journal of Neurology. 29(9). 2792–2800. 4 indexed citations
6.
Li, Rui, Bingjun Zhang, Yuge Wang, et al.. (2022). Disease Course and Outcomes in Patients With the Limited Form of Neuromyelitis Optica Spectrum Disorders and Negative AQP4-IgG Serology at Disease Onset: A Prospective Cohort Study. Journal of Clinical Neurology. 18(4). 453–453. 7 indexed citations
7.
Han, Fei, Tian Li, Mengmeng Li, et al.. (2022). Nano-calcium silicate mineralized fish scale scaffolds for enhancing tendon-bone healing. Bioactive Materials. 20. 29–40. 42 indexed citations
8.
Sun, Yuhua, Bingjun Zhang, Dong Zhai, & Chengtie Wu. (2021). Three-dimensional printing of bioceramic-induced macrophage exosomes: immunomodulation and osteogenesis/angiogenesis. NPG Asia Materials. 13(1). 38 indexed citations
9.
Dai, Yongqiang, et al.. (2021). Bridging Therapy for Acute Stroke as the Initial Manifestation of Takayasu Arteritis: A Case Report and Review of Literature. Frontiers in Immunology. 12. 630619–630619. 4 indexed citations
10.
Hu, Mengyan, Yinyao Lin, Xuejiao Men, et al.. (2021). High-salt diet downregulates TREM2 expression and blunts efferocytosis of macrophages after acute ischemic stroke. Journal of Neuroinflammation. 18(1). 90–90. 31 indexed citations
11.
Zhang, Bingjun, et al.. (2020). Serum Systemic Autoantibodies in Anti-N-Methyl-D-Aspartate Receptor Encephalitis. Frontiers in Neurology. 11. 117–117. 2 indexed citations
12.
Liu, Libin, Mingyu Yin, Sanxin Liu, Mengyan Hu, & Bingjun Zhang. (2020). Facial filler causes stroke after development of cerebral fat embolism. The Lancet. 395(10222). 449–449. 9 indexed citations
13.
Shan, Yilong, Sha Tan, Yinyao Lin, et al.. (2019). The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke. Journal of Neuroinflammation. 16(1). 242–242. 139 indexed citations
14.
Zhou, Li, Sha Tan, Yilong Shan, et al.. (2016). Baicalein improves behavioral dysfunction induced by Alzheimer’s disease in rats. Neuropsychiatric Disease and Treatment. Volume 12. 3145–3152. 35 indexed citations
15.
Lin, Yinyao, Lei Zhang, Yongqiang Dai, et al.. (2015). Expression of interleukin-9 and its upstream stimulating factors in rats with ischemic stroke. Neurological Sciences. 36(6). 913–920. 9 indexed citations
16.
Bao, Jian, et al.. (2013). Dynamic changes of leukocytes and prognoses of patients with right and left middle cerebral artery infarction: a comparative study. Chinese Journal of Neuromedicine. 12(8). 801–805. 1 indexed citations
17.
Men, Xuejiao, et al.. (2013). Homocysteine and C-Reactive Protein Associated with Progression and Prognosis of Intracranial Branch Atheromatous Disease. PLoS ONE. 8(9). e73030–e73030. 27 indexed citations
18.
Men, Xuejiao, Aimin Wu, Bingjun Zhang, et al.. (2013). Leukoaraiosis and NIHSS score help to differentiate subtypes of intracranial branch atheromatous disease in Southern Han Chinese patients with stroke. Neurological Sciences. 34(10). 1727–1733. 19 indexed citations
19.
Lu, Zhengqi, Bingjun Zhang, Wei Qiu, et al.. (2011). Comparative Brain Stem Lesions on MRI of Acute Disseminated Encephalomyelitis, Neuromyelitis Optica, and Multiple Sclerosis. PLoS ONE. 6(8). e22766–e22766. 51 indexed citations
20.
Domínguez, M.A., et al.. (2010). Brain-derived neurotrophic factor expression in granulosa lutein cells. Reproductive BioMedicine Online. 22(1). 17–24. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026